University of Iowa Hosptials and Clinics
Iowa City, Iowa, 52242, United States
NCT Number: NCT01975974
Obtaining peripheral vascular access in medical patients is a necessary procedure for many healthcare providers. Peripheral vascular access is traditionally performed using palpation or visual inspection to identify appropriate points of entry in the vasculature after which a needle and catheter are threaded through the skin and surround fascia into the vessel of interest. This procedure, one of the most common procedures in the medical field including both artery and vein access, is not 100% successfully attempted. Operator skill heavily influences peripheral vascular cannulation. (Frisch et al. 2013) However, certain patient populations have difficult peripheral vessels to identify by palpation or visual inspection and past operators would be forced to perform the procedure blind based on anatomical landmarks. Recently, to aid vascular identification and increase cannulation success, a number of alternative techniques for peripheral vascular access have been described including ultrasound-guided.
Ultrasound-guided vascular access has been utilized in vascular access with improved success rate. However, even with ultrasound guidance the first attempt success rate of cannulation was only approximately 65%. A proposed failure of ultrasound guided peripheral vascular access is most likely due to failure to advance the catheter into the vessel even the vessel was successfully punctured. The investigators propose a specific technique and the positive "Target Sign" as a means to obtain almost 100% successful peripheral vascular access.
The investigators plan to enroll 100 surgical patients in the above study and study procedures will not differ from what a patient in the operating room under the care of anesthesia faculty would receive. The above study is simply a way to identify the steps regarding a specific technique.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Iowa City, Iowa, 52242, United States
The subjects (patients) will be brought to the Main Operating Room after their time in the Day of Surgery Admissions (DOSA) at the discretion of the attending physicians and surgical team. The patients will not be required to do anything different from standard anesthesia and surgical practice at the hospital. Subjects will come to the operating room suite and the usual monitors (electrocardiogram, non-invasive blood pressure, and oxygen saturation) will be placed.
Prior to the routine induction of anesthesia, peripheral vascular access is usually obtained. In regards to the subject population, peripheral vascular access is predicted to be more difficult due to lack of visualization of the peripheral vessels. The skin will be prepped with chlorhexidine, draped, and all subsequent procedures will be performed in sterile fashion. The attending physician and/or resident will use the L25x Sonosite transducer with the Sonosite Edge® (Washington, US) to identify a peripheral vessel in the upper extremity for cannulation. After identification of the vessel, the operator will line the L25x Sonosite transducer to place the vessel horizontally midline on the Sonosite Edge® screen to give the most available viewing area. A BD Insyte® Autoguard® 16G shielded IV catheter (Becton Dickinson Infusion Therapy Systems Inc., Utah, US) will be advanced toward the vessel at an approximately 10˚ angle. Once the needle tip is identified on the Sonosite Edge® monitor in short axis view, the following steps will ensue:
Number of attempts and time to successful vessel cannulation will be measured, starting from when either the operator's fingers or the ultrasound probe made contact with the patient's skin. Successful vessel cannulation will be defined as a flowing IV bag of saline after connection and confirmation of flow via fluid agitation in vessel identified via ultrasound.
This procedure will be incorporated in the subjects standard of care and will not extend the time of operation.
At this point, patient participation in the study will be over and surgical operation under the discretion of the surgical team. The video recording of the Target Sign will be saved and given to a member of the research team unknowing of the success of the cannulation. The member of the research team will decide, based on the ultrasound video recording of a positive or negative Target Sign, if the cannulation was successful or unsuccessful. The viewer will record his/her answers and compare with the actual result of the cannulation.
Analysis of unsuccessful and successful cannulations will be compared with a Positive or Negative Target Sign. No additional long-term followup will occur.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Using ultrasound as a guide for peripheral venous cannulation in obese patients
Time frame: one day
we will compare the first attempt success rate using proposed ultrasound technique in total of 100 obese (BMI>30) surgical patients with existing published data. Mata-analysis of first attempt success rate using ultrasound for intravenous cannulation is 61.8% We predict 90% (50% improvement) success rate using the proposed ultrasound technique. Based on this prediction, a sample size of 100 patients provided more than 90% power to compare there two groups at the 0.05 significance level with a two-sided Chi square test.
University of Iowa
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04598685
Arterial Occlusive Diseases, Arteriosclerosis
Innsbruck, Tyrol, Austria
View Trial DetailsNCT03219749
Apnea, Body Weight
Towson, Maryland, United States
View Trial DetailsNCT00000501
Body Weight, Cardiovascular Diseases
View Trial DetailsNCT00000506
Body Weight, Cardiovascular Diseases
View Trial Details